NCT04574024View on ClinicalTrials.gov

HFS (High-Fiber Supplement) in MS (Multiple Sclerosis)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

July 15, 2024

Conditions

Multiple Sclerosis

Interventions

DRUG

NBT-NM108

MS Patients received NBT-NM108 at 60 g/day.

Trial Locations (1)

08901

Robert Wood Johnson University Hospital, New Brunswick

All Listed Sponsors

lead

Suhayl Dhib-Jalbut, MD

OTHER